Related Experiment Video

Updated: Jun 10, 2026

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
10:32

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model

Published on: April 2, 2021

Update on retinopathy of prematurity: treatment options and outcomes

Jonathan H Salvin1, Sharon S Lehman, Jing Jin

  • 1Division of Ophthalmology, Nemours/A.I. duPont Hospital for Children, Wilmington, Delaware 19803, USA. jsalvin@nemours.org

Current Opinion in Ophthalmology
|July 17, 2010
PubMed

Insights

Recent advancements in retinopathy of prematurity (ROP) include updated screening guidelines and novel antiangiogenic therapies. This review highlights improved outcomes and the necessity of lifelong ophthalmology care for treated patients.

Area of Science:

  • Ophthalmology
  • Neonatology
  • Pediatric Medicine

Background:

  • Retinopathy of prematurity (ROP) is a significant cause of visual impairment in premature infants.
  • Early detection and intervention are crucial for managing ROP and preventing severe visual loss.

Purpose of the Study:

  • To review recent scientific literature on retinopathy of prematurity (ROP).
  • To compile advancements in ROP treatment options and outcomes.
  • To update on current screening and treatment guidelines.

Main Methods:

  • Literature review of recent scientific studies on ROP.
  • Compilation of findings on treatment advancements and patient outcomes.

Main Results:

  • New ROP screening and treatment guidelines are established as the standard of care.
  • Antiangiogenic therapies present new primary or adjunct treatment options alongside laser therapy.
  • Follow-up data reveal short- and long-term complications necessitating ongoing ophthalmology care.

Conclusions:

  • This review provides an update on ROP screening and treatment.
  • It highlights new therapeutic approaches and discusses essential long-term management strategies.
  • Emphasis is placed on the lifelong ophthalmology care required for ROP patients.
Abstract

More Related Videos

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents09:28

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Published on: September 16, 2020

Related Concept Videos

Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...